- Home
- RCKT vs FSTR Comparison
RCKT vs FSTR Comparison
Compare RCKT & FSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- FSTR
- Stock Information
- Founded
- RCKT 1999
- FSTR 1902
- Country
- RCKT United States
- FSTR United States
- Employees
- RCKT N/A
- FSTR N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- FSTR Metal Fabrications
- Sector
- RCKT Health Care
- FSTR Industrials
- Exchange
- RCKT Nasdaq
- FSTR Nasdaq
- Market Cap
- RCKT 328.6M
- FSTR 285.6M
- IPO Year
- RCKT N/A
- FSTR N/A
- Fundamental
- Price
- RCKT $3.17
- FSTR $25.90
- Analyst Decision
- RCKT Buy
- FSTR Hold
- Analyst Count
- RCKT 13
- FSTR 1
- Target Price
- RCKT $12.88
- FSTR $25.00
- AVG Volume (30 Days)
- RCKT 2.3M
- FSTR 27.3K
- Earning Date
- RCKT 11-06-2025
- FSTR 11-06-2025
- Dividend Yield
- RCKT N/A
- FSTR N/A
- EPS Growth
- RCKT N/A
- FSTR 395.33
- EPS
- RCKT N/A
- FSTR 3.32
- Revenue
- RCKT N/A
- FSTR $506,999,000.00
- Revenue This Year
- RCKT N/A
- FSTR $3.93
- Revenue Next Year
- RCKT $108.43
- FSTR $4.51
- P/E Ratio
- RCKT N/A
- FSTR $7.80
- Revenue Growth
- RCKT N/A
- FSTR N/A
- 52 Week Low
- RCKT $2.19
- FSTR $17.16
- 52 Week High
- RCKT $18.89
- FSTR $29.78
- Technical
- Relative Strength Index (RSI)
- RCKT 48.26
- FSTR 46.48
- Support Level
- RCKT $3.13
- FSTR $26.22
- Resistance Level
- RCKT $3.44
- FSTR $26.90
- Average True Range (ATR)
- RCKT 0.17
- FSTR 0.81
- MACD
- RCKT -0.01
- FSTR -0.25
- Stochastic Oscillator
- RCKT 35.11
- FSTR 4.48
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About FSTR L.B. Foster Company
L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.